A Chimeric GM-CSF/IL18 Receptor to Sustain CAR T-cell Function.

Lange, Shannon; Sand, Laurens G L; Bell, Matthew; Patil, Sagar L; Langfitt, Deanna; Gottschalk, Stephen

Lange, Shannon; Sand, Laurens G L; Bell, Matthew; Patil, Sagar L; Langfitt, Deanna; Gottschalk, Stephen.

Afiliação

Lange S; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
Sand LGL; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
Bell M; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
Patil SL; Graduate School of Biomedical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.
Langfitt D; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.
Gottschalk S; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee.

Cancer Discov ; 11(7): 1661-1671, 2021 07.

Article em En | MEDLINE | ID: mdl-33563660

Assuntos

Imunoterapia Adotiva; Interleucina-18; Neoplasias/terapia; Receptores de Antígenos Quiméricos; Receptores de Fator Estimulador das Colônias de Granulócitos e Macrófagos; Animais; Linhagem Celular Tumoral; Humanos; Leucócitos Mononucleares; Camundongos; Ensaios Antitumorais Modelo de Xenoenxerto

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Receptores de Fator Estimulador das Colônias de Granulócitos e Macrófagos / Interleucina-18 / Receptores de Antígenos Quiméricos / Neoplasias Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google